FDA Approves Piqray
FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer
May 24, 2019 -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine t
Novartis Issues Voluntary Nationwide Recall of Promacta 12.5 mg for Oral Suspension Due to Potential Peanut Contamination
Audience: Consumer, Health Professional, Pharmacy
May 11, 2019 -- Novartis today announced a voluntary recall of three lots of Pr
Water Polo Study Highlights Head Injury Risk
SATURDAY, May 25, 2019 -- Water polo players appear to face similar head injury risks as athletes in better-known sports, a new study FINDS.
"For years, water polos head trauma risks have been downplayed or
FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients
RALEIGH, N.C. – May 13, 2019 – Merz Americas announced today that the U.S. Food and Drug Administra
FDA Approves Ruzurgi
FDA Approves Ruzurgi (amifampridine) for Children with Lambert-Eaton Myasthenic Syndrome
May 06, 2019 -- The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myast
Colon Cancer Increasingly Striking the Young Worldwide
FRIDAY, May 17, 2019 -- The rise in colon cases among younger adults thats been seen in the United States is also occurring in wealthier nations worldwide, new research shows.
In the decade leadin